DE60029327D1 - Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe - Google Patents

Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Info

Publication number: DE60029327D1
Authority: DE; Germany
Prior art keywords: acid sequences; nucleic acid; amino; vaccines; anaemia virus
Prior art date: 1999-08-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60029327T

Other languages

English (en)

Other versions

DE60029327T2 (de

Inventor

Steven Griffiths

Jane Ritchie

Joel Heppell

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Novartis AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-07

Filing date

2000-08-07

Publication date

2006-08-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60029327(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-08-07 Priority claimed from GBGB9918588.6A external-priority patent/GB9918588D0/en

2000-03-11 Priority claimed from GB0005848A external-priority patent/GB0005848D0/en

2000-03-21 Priority claimed from GB0006674A external-priority patent/GB0006674D0/en

2000-08-07 Application filed by Novartis AG filed Critical Novartis AG

2006-08-24 Publication of DE60029327D1 publication Critical patent/DE60029327D1/de

2007-07-05 Application granted granted Critical

2007-07-05 Publication of DE60029327T2 publication Critical patent/DE60029327T2/de

2020-08-08 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Color Image Communication Systems (AREA)
Saccharide Compounds (AREA)
Paper (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DE60029327T 1999-08-07 2000-08-07 Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe Expired - Lifetime DE60029327T2 (de)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
GBGB9918588.6A GB9918588D0 (en)	1999-08-07	1999-08-07	Sequence
GB9918588		1999-08-07
GB0005848		2000-03-11
GB0005848A GB0005848D0 (en)	2000-03-11	2000-03-11	Sequence
GB0006674		2000-03-21
GB0006674A GB0006674D0 (en)	2000-03-21	2000-03-21	Sequence
PCT/GB2000/002976 WO2001010469A2 (en)	1999-08-07	2000-08-07	Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines

Publications (2)

Publication Number	Publication Date
DE60029327D1 true DE60029327D1 (de)	2006-08-24
DE60029327T2 DE60029327T2 (de)	2007-07-05

Family

ID=27255591

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60029327T Expired - Lifetime DE60029327T2 (de)	1999-08-07	2000-08-07	Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Country Status (12)

Country	Link
US (7)	US6919083B1 (de)
EP (2)	EP1200132B2 (de)
AT (1)	ATE332712T1 (de)
AU (1)	AU6304100A (de)
CA (1)	CA2378437C (de)
CY (1)	CY1106175T1 (de)
DE (1)	DE60029327T2 (de)
DK (2)	DK1200132T4 (de)
ES (1)	ES2267553T3 (de)
NO (1)	NO328740B1 (de)
PT (1)	PT1200132E (de)
WO (1)	WO2001010469A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001010469A2 (en)	1999-08-07	2001-02-15	Novartis Ag	Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
ATE286507T1 (de) *	1999-10-18	2005-01-15	Akzo Nobel Nv	Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen
WO2001066569A1 (en) *	2000-03-08	2001-09-13	The University Court Of The University Of Aberdeen	Viral antigen and vaccine against isav (infectious salmon anaemia virus)
WO2002026784A2 (en) *	2000-09-28	2002-04-04	Akzo Nobel N.V.	Matrix proteins m1 and m2 of infections salmon anaemia virus
GB0216414D0 (en)	2002-07-15	2002-08-21	Novartis Ag	Organic compounds
CA2687208C (en)	2006-12-22	2017-02-14	Soluciones Biotecnologicas Innovacion Ltda	Process and formulation for immunizing fish in aquaculture systems
CN102647988A (zh)	2009-10-02	2012-08-22	纽约市哥伦比亚大学理事会	鱼呼肠弧病毒免疫原性组合物
US20130243803A1 (en) *	2012-03-09	2013-09-19	Samuel Bogoch	Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO311648B1 (no)	1999-05-31	2001-12-27	Genomar Asa	DNA-sekvenser som kan benyttes til vaksine, forebyggende helsearbeid på fisk og akvatiske organismer og ellers innenbiomedisin, vektor, vaksine mot ILA-virus samt diagnostisk sett
WO2001010469A2 (en)	1999-08-07	2001-02-15	Novartis Ag	Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
ATE286507T1 (de)	1999-10-18	2005-01-15	Akzo Nobel Nv	Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen
AU3539401A (en)	2000-01-07	2001-07-16	Akzo Nobel N.V.	Vaccine for prevention and/or prophylaxis of infectious salmon anaemia in fish
WO2001066569A1 (en)	2000-03-08	2001-09-13	The University Court Of The University Of Aberdeen	Viral antigen and vaccine against isav (infectious salmon anaemia virus)
WO2002026784A2 (en)	2000-09-28	2002-04-04	Akzo Nobel N.V.	Matrix proteins m1 and m2 of infections salmon anaemia virus

2000
- 2000-08-07 WO PCT/GB2000/002976 patent/WO2001010469A2/en active IP Right Grant
- 2000-08-07 CA CA2378437A patent/CA2378437C/en not_active Expired - Lifetime
- 2000-08-07 AT AT00949769T patent/ATE332712T1/de not_active IP Right Cessation
- 2000-08-07 EP EP00949769A patent/EP1200132B2/de not_active Expired - Lifetime
- 2000-08-07 US US10/049,086 patent/US6919083B1/en not_active Expired - Lifetime
- 2000-08-07 DK DK00949769.4T patent/DK1200132T4/da active
- 2000-08-07 ES ES00949769T patent/ES2267553T3/es not_active Expired - Lifetime
- 2000-08-07 DE DE60029327T patent/DE60029327T2/de not_active Expired - Lifetime
- 2000-08-07 EP EP05018866A patent/EP1637614A3/de not_active Withdrawn
- 2000-08-07 AU AU63041/00A patent/AU6304100A/en not_active Abandoned
- 2000-08-07 PT PT00949769T patent/PT1200132E/pt unknown
2002
- 2002-02-05 NO NO20020573A patent/NO328740B1/no not_active IP Right Cessation
- 2002-02-05 DK DKPA200200167A patent/DK177298B1/da not_active IP Right Cessation
2004
- 2004-04-02 US US10/734,782 patent/US7128917B2/en not_active Expired - Lifetime
2005
- 2005-03-18 US US11/083,800 patent/US7201910B2/en not_active Expired - Lifetime
- 2005-03-18 US US11/083,801 patent/US7199108B2/en not_active Expired - Lifetime
2006
- 2006-09-22 US US11/525,695 patent/US20070041988A1/en not_active Abandoned
- 2006-09-28 CY CY20061101410T patent/CY1106175T1/el unknown
2009
- 2009-11-24 US US12/624,918 patent/US7998484B2/en not_active Expired - Fee Related
2011
- 2011-08-12 US US13/208,709 patent/US20120071630A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CY1106175T1 (el)	2011-06-08
EP1637614A2 (de)	2006-03-22
EP1637614A3 (de)	2006-11-29
NO20020573D0 (no)	2002-02-05
EP1200132B2 (de)	2010-02-17
ES2267553T3 (es)	2007-03-16
US20040146860A1 (en)	2004-07-29
US20120071630A1 (en)	2012-03-22
DK1200132T4 (da)	2010-04-19
AU6304100A (en)	2001-03-05
WO2001010469A3 (en)	2001-09-07
US6919083B1 (en)	2005-07-19
EP1200132B1 (de)	2006-07-12
DK200200167A (da)	2002-04-02
US20070041988A1 (en)	2007-02-22
US7998484B2 (en)	2011-08-16
NO328740B1 (no)	2010-05-03
US20100136038A1 (en)	2010-06-03
DK1200132T3 (da)	2006-10-23
DK177298B1 (en)	2012-10-15
PT1200132E (pt)	2006-11-30
US20050261227A1 (en)	2005-11-24
WO2001010469A2 (en)	2001-02-15
DE60029327T2 (de)	2007-07-05
US20050164176A1 (en)	2005-07-28
NO20020573L (no)	2002-04-05
EP1200132A2 (de)	2002-05-02
CA2378437A1 (en)	2001-02-15
ATE332712T1 (de)	2006-08-15
US7128917B2 (en)	2006-10-31
US7199108B2 (en)	2007-04-03
US7201910B2 (en)	2007-04-10
CA2378437C (en)	2014-01-21

Publication	Publication Date	Title
DK0804584T3 (da)	2002-09-23	Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
ATE318309T1 (de)	2006-03-15	Hcv-spezifische peptide, mittel dazu und ihre verwendung
GR3017770T3 (en)	1996-01-31	Feline infectious peritonitis virus diagnostic tools.
DE69030124D1 (de)	1997-04-10	Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
ES2144399T3 (es)	2000-06-16	Clonado del adn de virus de anemia de los pollos.
DE60029327D1 (de)	2006-08-24	Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
ATE349533T1 (de)	2007-01-15	Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
DE60138703D1 (de)	2009-06-25	Transportpeptide abgeleitet von erns protein
NO20005608L (no)	2000-11-07	Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav
ATE346087T1 (de)	2006-12-15	Hepatitis e-virus aus dem schwein und dessen verwendungen
EP1878797A3 (de)	2008-01-23	Antigene Peptide zur Gruppierung des Hepatitis-C-Virus, Kit damit und Verfahren zur Gruppierung unter Verwendung dieses Kits
ATE109158T1 (de)	1994-08-15	Rubella-e1 und c peptide.
NO20005217D0 (no)	2000-10-17	DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav
ATE235553T1 (de)	2003-04-15	Protein p100von menschlichem herpesvirus typ 6, die korrespondierenden dns squenzen, ihre herstellung und verwendung
DK1077999T3 (da)	2007-05-29	Moraxella catarrhalis-proteiner
EP1191096A4 (de)	2004-06-02	Neues protein und dessen dns
ATE359293T1 (de)	2007-05-15	Von vca-p18 kapsidantigen des epstein-barr-virus abgeleitete peptide und ihre verwendung
DE60120391D1 (de)	2006-07-20	Verwendung von hev-polypeptiden
DE60129228D1 (de)	2007-08-16	Humane 7-transmembranproteine und dafür codierende polynukleotide
ZA982996B (en)	1999-10-08	Synthetic peptides which can be used in biological tests for the detection of infections due to group O HIV-1 viruses.
TW369600B (en)	1999-09-11	Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same

Legal Events

Date	Code	Title	Description
2007-06-21	8363	Opposition against the patent
2009-07-30	8328	Change in the person/name/address of the agent	Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC
2010-04-29	8366	Restricted maintained after opposition proceedings
2011-01-27	8332	No legal effect for de